Bio-Plexus CEO John Metz talks to The Wall Street Transcript.Business Editors NEW YORK--(BUSINESS WIRE)--July 17, 2000 The Wall Street Transcript has published an in-depth interview with John Metz, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Bio-Plexus (Nasdaq:BPLX), in which he talks at length about the company's future. The entire 1,900-word interview is available free online at http://www.twst.com/ceos.htm Metz gives an overview of his company, "Bio-Plexus designs, develops, manufactures, and markets products that are medical devices that help safely collect blood or deliver medication. Our patented Punctur-Guard(R) technology is the only technology available that can be made safe while still inside the patient. So, for example, if a phlebotomist phle·bot·o·mist n. 1. One who practices phlebotomy. 2. One who draws blood for analysis or transfusion. or other healthcare worker is drawing blood and they are using one of our safety needles, the Needles, the, England: see Wight, Isle of. worker can actually activate the device such that the needle becomes blunt -- safe -- while still inside the patient." Metz explains, "Healthcare workers, those who care for us when we are sick, must be protected and especially in such a critical area as avoiding a potential infection from HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. or hepatitis C Hepatitis C Definition Hepatitis C is a form of liver inflammation that causes primarily a long-lasting (chronic) disease. Acute (newly developed) hepatitis C is rarely observed as the early disease is generally quite mild. , which lead ultimately to termination of life. Our Punctur-Guard Safety needles consistently receive top ratings in product studies. Punctur-Guard works better than competing products. Globally, we have a huge market opportunity." Looking forward, Metz states, "The other thing helping to drive this are federal OSHA OSHA n. Occupational Safety and Health Administration, a branch of the US Department of Labor responsible for establishing and enforcing safety and health standards in the workplace. regulations and state legislation that requires the use of a safety needle device. We're a small company. We are public. There are not a lot of opportunities where such a clear change in the marketplace in medical devices is occurring: Bio-Plexus is a good place to look if you want to invest in the medical arena. We've plenty of room to grow, and that should make our stock attractive to a lot of people." This interview is part of a 110-page Drug & Medical Supply Distributors Issue available at http://www.twst.com/info/info132.htm or by calling (212) 952-7433 The Wall Street Transcript is a premier weekly investment publication serving serious long-term investors Long-term investor A person who makes investments for a period of at least five years in order to finance his or her long-term goals. for over 37 years. The Wall Street Transcript has launched a new free service where investors can ask Bio-Plexus (or any public company) a question at http://www.qawire.com The Wall Street Transcript does not endorse the views of any interviewees nor does it make stock recommendations. For subscription information call (800) 246-7673. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion